SOURCE: Bar Harbor BioTechnology Inc.

March 06, 2008 07:00 ET

Bar Harbor BioTechnology Inc. Launches a New Line StellARrays™

TRENTON, ME--(Marketwire - March 6, 2008) - Bar Harbor BioTechnology Inc. announced the launch of its new line of human StellARray™ products for gene expression research today. This initial offering of 43 different biological pathways for scientists to select from includes many major human diseases. Configured to perform gene expression or gene copy number experiments these new Real-Time PCR arrays are the first of their kind in the field of gene expression research.

"Scientists researching human diseases like obesity, osteoporosis, and Alzheimer's disease have a new method for detecting subtle changes in how a group of genes are expressed. That could lead to a breakthrough in their research," says Robert Phelps, President of Bar Harbor BioTechnology Inc.

In September 2006, Bar Harbor BioTechnology Inc. spun off from The Jackson Laboratory taking with it an exclusive license to commercialize the Global Pattern Recognition™ algorithm. Used in conjunction with StellARrays™ scientists can obtain a new way to see small yet significant changes in gene expression.

"It is very similar to taking an image of the night sky and comparing it to another image taken at a different time. Most of the stars will align. It's the small shifts or changes that dramatically show up that prove to be significant," says Dan Shaffer, VP of Production.

The company has plans to expand its existing product selection of 46 mouse and 43 human Real-Time PCR arrays to include areas of cancer, metabolism, immunology, stem cell, and neurology research. Since its initial entrance into the gene expression market on October 1, 2007, the company reports selling StellARrays™ to major research facilities including Harvard Medical School, National Institute for Health, and Merck Pharmaceuticals Inc.

© 2008 Bar Harbor BioTechnology Inc. All rights reserved.

Bar Harbor BioTechnology Inc. undertakes no obligation to release publicly the results of any revisions to any forward-looking statement made or implied in this release, which may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events. Statements in this release should be evaluated accordingly.

Contact Information